EYPT FY2025 EPS Estimate Lowered by Cantor Fitzgerald
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Research analysts at Cantor Fitzgerald lowered their FY2025 EPS estimates for shares of EyePoint Pharmaceuticals in a report released on Thursday, May 8th. Cantor Fitzgerald analyst J. Kim now expects that the company will post earnings of ($3.15) per share for the year, down from their prior […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Research analysts at Cantor Fitzgerald lowered their FY2025 EPS estimates for shares of EyePoint Pharmaceuticals in a report released on Thursday, May 8th. Cantor Fitzgerald analyst J. Kim now expects that the company will post earnings of ($3.15) per share for the year, down from their prior […]
